This study is currently not recruiting participants.

A Prospective Database of Patients Undergoing Fibroscan for Assessment of Liver Fibrosis

Investigation of Liver Fibrosis Evaluation Using a Medical Device

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The aim of this study is to maintain a prospective database of people who undergo evaluation for liver fibrosis using FibroScan?, a device that recently received 510(k) clearance from the U.S. Food and Drug Administration.

Detailed description of study

The aim of this study is to maintain a prospective database of people who undergo evaluation for liver fibrosis using FibroScan?, a device that recently received 510(k) clearance from the U.S. Food and Drug Administration.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Fibrosis
  • Age: 100 years or below
  • Gender: All

This study investigates the evaluation of liver fibrosis using a device called FibroScan. Liver fibrosis is a condition where the liver becomes scarred due to long-term damage. The FibroScan device uses a special technology to measure the stiffness of the liver, which helps determine the level of fibrosis.

Participants in the study will undergo evaluation with the FibroScan device. This involves a non-invasive procedure where a probe is placed on the skin to send sound waves to the liver, measuring its stiffness. The data collected will be used to maintain a database for future research.

  • Who can participate: Eligibility criteria are not specified for this study. The study is open to all individuals undergoing liver fibrosis evaluation.
  • Study details: Participants will have their liver evaluated using the FibroScan device. This involves a non-invasive test with a probe that measures liver stiffness. The collected data will contribute to a research database.
Updated on 19 Feb 2024. Study ID: 1306011673

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team